Current Status of Selective Estrogen Receptor Modulators (SERMs)
- 1 January 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Cancer Journal
- Vol. 9 (1) , 4-14
- https://doi.org/10.1097/00130404-200301000-00003
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Phase III Evaluation of Fluoxetine for Treatment of Hot FlashesJournal of Clinical Oncology, 2002
- Diethylstilbestrol regulates trophoblast stem cell differentiation as a ligand of orphan nuclear receptor ERRβGenes & Development, 2001
- Selective Estrogen Receptor Modulation: The Search for an Ideal Hormonal Therapy for Breast CancerCancer Investigation, 2001
- Selective Estrogen Receptor Modulators: Structure, Function, and Clinical UseJournal of Clinical Oncology, 2000
- Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysisBreast Cancer Research and Treatment, 1999
- The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by TamoxifenPublished by Elsevier ,1998
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Molecular basis of agonism and antagonism in the oestrogen receptorNature, 1997
- Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast CancerNew England Journal of Medicine, 1992
- A NEW DERIVATIVE OF TRIPHENYLETHYLENE: EFFECT ON IMPLANTATION AND MODE OF ACTION IN RATSReproduction, 1967